Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression
about
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future AntidepressantsMicroinfusion of bupropion inhibits putative GABAergic neuronal activity of the ventral tegmental area.Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus.Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone.Biochemical assessment of antidepressive drugs.Neuroplasticity underlying the comorbidity of pain and depressionInfluence of amineptine on changes of blood pressure evoked by norepinephrine and dopamineInnovative approaches for the development of antidepressant drugs: current and future strategiesThe circadian clock and mood-related behaviorAcute systemic infusion of bupropion decrease formalin induced pain behavior in rat.The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice.Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius.Second generation antidepressants: a comparative review.Specific tricyclic antidepressant binding sites in rat brain.Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin.Rem sleep deprivation in an experimental model of Parkinson's disease.Increased stimulated release and uptake of dopamine in nucleus accumbens after repeated cocaine administration as measured by in vivo voltammetry.Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transporters.Study on the effect of EMD386088, a 5-HT6 receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats.Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens.Retinal dysfunction of contrast processing in major depression also apparent in cortical activity.Differing neurotoxic potencies of methamphetamine, mazindol, and cocaine in mesencephalic cultures.Chronic treatment with iprindole reduces immobility of rats in the behavioural 'despair' test by activating dopaminergic mechanisms in the brain.Assessment of dopamine release by in vivo microdialysis in the nucleus accumbens of rats following acute and chronic administration of desipramine.COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder.Effects of antidepressant drugs on dopamine uptake and metabolism.Total sleep deprivation and Parkinson disease.Failure of mianserin to affect autonomic function in the pupils of depressed patients.
P2860
Q28082891-CA4CB49A-F3EB-4E7C-AEFF-3B06CC9B4B02Q34367958-63BE7554-D4A6-43A7-9467-0D01D132F855Q34429428-7FA4A457-FBB0-46CA-A67D-1F3C9E33B710Q34514099-8FFA89D7-5500-452B-8D97-6A57EF74A154Q34519631-98B32EE8-8184-4D33-AAB7-0DE40CC36389Q35165267-8FCEDC2F-F862-4849-A189-F43CBFE78AF4Q35939213-2DC4E25B-E4EA-4A14-A013-7069C6F9F193Q36401400-4BA8D802-3AEE-4B1F-B852-6E6219B91E53Q37079552-FEE70E7E-BCDB-47CA-A8AA-D6EB1079E948Q37709123-B4676C77-D037-4225-8DFA-8BB4E43CA36CQ38025454-7B36E793-48D7-40BE-B6C4-07479DA681F8Q39143939-E149C84D-5A56-4126-9466-DA9E86C33AEDQ39170724-A0FE1280-BA44-4968-8B73-674DF105C8A6Q39822808-F9C6C3C5-D4CF-424D-828B-ADF918AC5EF0Q41752061-0280955B-050C-4938-AD6A-BEAA5335EB3FQ42191443-FE2CA711-0C0C-4389-9FC9-C7462E573630Q42657228-AD3E095E-BC32-4616-BB59-BA59665F9470Q43647739-18748F9F-AB2A-4321-84B5-55F2F4183F10Q43805996-B38689C2-D27F-43B3-B6B7-8D02BC71269CQ47996823-BFA89E8F-E1C5-442E-9220-E1C51D9360C8Q48119859-40120339-FE1C-4AE5-8253-EC6587386A3CQ48138526-6C1F37C7-ECFA-4F2B-920E-A4926F6F8E5FQ48316871-99285279-86CB-48FC-B45D-88B82DCC7312Q48363887-0DA97CC0-F0B8-4007-AB31-5900DC58E2F6Q48467273-66AF83BF-4D64-4E09-B23D-BDD9D79E0077Q48467816-4107F402-29FF-4D51-8966-5FD8C4796C85Q48942593-52DC2FDB-46B7-4E8D-B743-B282CFFF1DB9Q48973226-4D3A3B2D-7A70-433D-BE2C-4F07CB5A0400Q53746119-18ED01FF-C893-42B5-B994-998B158E1F35
P2860
Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression
description
1977 nî lūn-bûn
@nan
1977 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Uptake inhibition of biogenic ...... amine hypothesis of depression
@ast
Uptake inhibition of biogenic ...... amine hypothesis of depression
@en
Uptake inhibition of biogenic ...... amine hypothesis of depression
@nl
type
label
Uptake inhibition of biogenic ...... amine hypothesis of depression
@ast
Uptake inhibition of biogenic ...... amine hypothesis of depression
@en
Uptake inhibition of biogenic ...... amine hypothesis of depression
@nl
prefLabel
Uptake inhibition of biogenic ...... amine hypothesis of depression
@ast
Uptake inhibition of biogenic ...... amine hypothesis of depression
@en
Uptake inhibition of biogenic ...... amine hypothesis of depression
@nl
P2860
P356
P1433
P1476
Uptake inhibition of biogenic ...... amine hypothesis of depression
@en
P2093
C Braestrup
P2860
P2888
P304
P356
10.1007/BF00492370
P407
P577
1977-08-16T00:00:00Z
P6179
1041227962